Format

Send to

Choose Destination
Cytokine. 2013 Nov;64(2):564-70. doi: 10.1016/j.cyto.2013.08.003. Epub 2013 Sep 6.

Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes.

Author information

1
Department of Cell and Molecular Biology, Madras Diabetes Research Foundation and Dr. Mohan's Diabetes Specialities Centre, Gopalapuram, Chennai, India.

Abstract

Despite the well known role of nucleotide oligomerization domain (NOD) receptor proteins in innate immunity, their association with diabetes is less explored. Here we report the transcriptional level of NODs and their downstream molecular signatures in CD14(+) monocytes from subjects with different grades of glucose tolerance. NOD1 and NOD2 mRNA expression were significantly up-regulated in monocytes from patients with type 2 diabetes (T2DM) and positively correlated with HOMA-IR and poor glycemic control. Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NFκB) along with the increased circulatory levels of TNF-α and IL-6. In vitro stimulation of monocytes with NOD specific ligands-i-EDAP and MDP significantly up regulated the mRNA expression of NOD1 and NOD2 respectively in T2DM. Our study exposes up regulation of NODs in monocytes as an important component of inflammation and insulin resistance in patients with T2DM.

KEYWORDS:

HOMA; HbA1C; IGT; IL-6; Inflammation; Innate immunity; Insulin resistance; MDP; NFκβ; NGT; NOD; Nucleotide oligomerization domain (NOD); OR; PGN; PRR; RIPK2; T2DM; TLR; TNF-α; Type 2 diabetes; glycated hemoglobin; homeostasis assessment model; iEDAP; impaired glucose tolerance; interleukin-6; muramyl dipeptide; normal glucose tolerance; nuclear factor kappa beta; nucleotide binding oligomerization domain; odds ratio; pattern recognition receptor; peptidoglycan; receptor interacting protein kinase 2; toll like receptor; tumor necrosis factor – alpha; type 2 diabetes mellitus; γ-d-glutamyl-meso diaminopimelic acid

PMID:
24018334
PMCID:
PMC4158007
DOI:
10.1016/j.cyto.2013.08.003
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center